Medtronic set to buy Ablation Frontiers for $225m
This article was originally published in Clinica
Executive Summary
In a bid to grow its atrial fibrillation (AF) offering, Medtronic is poised to purchase Ablation Frontiers for a fee of $225m plus potential milestones.